Ontology highlight
ABSTRACT: Background
Recent approval of the new oral anticoagulants dabigatran and rivaroxaban has led to rapid changes in anticoagulant prescribing practices. Postmarketing reports have highlighted safety concerns with these agents, and their use outside of evidence-based recommendations was noted at the authors' centre.Objectives
To determine the incidence of and risk factors associated with inappropriate prescribing of dabigatran and rivaroxaban.Methods
This retrospective cohort study investigated randomly selected dabigatran or rivaroxaban prescriptions for patients admitted to a tertiary teaching hospital between January 2010 and December 2012. Appropriateness of prescribing was determined from the documented indication, drug dosage, patient's renal function, and presenc
SUBMITTER: Chowdhry U
PROVIDER: S-EPMC4924939 | biostudies-literature | 2016 May-Jun
REPOSITORIES: biostudies-literature